136
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Generalized exponentiated unit Gompertz distribution for modeling arthritic pain relief times data: classical approach to statistical inference

ORCID Icon, &
Pages 323-348 | Received 30 Jun 2020, Accepted 01 May 2023, Published online: 29 May 2023
 

ABSTRACT

Arthritis is the tenderness and swelling of one or more of the joints. Arthritis therapies are directed mainly at reducing symptoms and improving quality of life. In this article, we introduced a novel four parametric model known as generalized exponentiated unit Gompertz (GEUG) for modeling a clinical trial data which represent the relief or relaxing times of arthritic patients receiving a fixed dosage of certain medication. The key feature of such novel model is the addition of new tuning parameters to unit Gompertz (UG) with the intention of increasing versatility of the UG model. We have derived and studied different statistical and reliable attributes, along with moments and associated measures, uncertainty measures, moments generating functions, complete/incomplete moments, quantile function, survival and hazard functions. A comprehensive simulation analysis is implemented to evaluate the effectiveness of estimation of distribution parameters using numerous well-known classical approaches, like maximum likelihood estimation (MLE), least squares estimation (LSE), weighted least squares estimation (WLSE), Anderson Darling estimation (ADE), right tail Anderson darling estimation (RTADE), and Cramer-Von Mises estimation (CVME). Finally, using a relief time’s data on arthritis pain show adaptability of suggested model. The results revealed that it might fit better than other relative models.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.